Cardiff Oncology Inc (CRDF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -38,635 | -27,377 | -13,434 | -45,431 | -33,644 |
| Depreciation Amortization | -414 | -251 | -44 | -194 | -132 |
| Accounts receivable | 519 | 247 | 368 | -484 | -330 |
| Other Working Capital | 2,661 | 3,458 | -681 | 3,172 | 2,794 |
| Other Operating Activity | 3,913 | 2,801 | 997 | 5,244 | 3,886 |
| Operating Cash Flow | $-31,956 | $-21,122 | $-12,794 | $-37,693 | $-27,426 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -9,363 | -19,541 | -14,584 | 13,808 | 9,297 |
| PPE Investments | -44 | -26 | N/A | -80 | -80 |
| Investing Cash Flow | $-9,407 | $-19,567 | $-14,584 | $13,728 | $9,217 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 28 | 3 | 3 | 53,780 | 9,592 |
| Financing Cash Flow | $28 | $3 | $3 | $53,780 | $9,592 |
| Beginning Cash Position | 51,470 | 51,470 | 51,470 | 21,655 | 21,655 |
| End Cash Position | 10,135 | 10,784 | 24,095 | 51,470 | 13,038 |
| Net Cash Flow | $-41,335 | $-40,686 | $-27,375 | $29,815 | $-8,617 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,956 | -21,122 | -12,794 | -37,693 | -27,426 |
| Capital Expenditure | -44 | -26 | N/A | -80 | -80 |
| Free Cash Flow | -32,000 | -21,148 | -12,794 | -37,773 | -27,506 |